A longtime in-house leader at GlaxoSmithKline is parting ways with the pharmaceutical giant to join Philadelphia-based biotech startup Passage Bio as general counsel. 

During his more than 20 years at GSK, Edgar “Chip” Cale has served as vice president, general counsel and, most recently, senior vice president of legal corporate projects. In that role, he oversaw GSK’s multinational legal team for the firm’s global business development and corporate matters. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]